Restrictions on interactions between doctors and industry could ultimately hurt patients

5Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Physician-industry collaboration has led to a diverse array of therapeutic advancements that have benefitted a broad spectrum of patient populations. Evolving regulations, both institutional and governmental, aiming to govern interactions between physicians and pharmaceutical and medical device manufacturers have become increasingly prevalent. Emerging data suggest that restrictions on physician-industry collaboration have the potential to harm patient care by degrading innovation and stifling medical education. The following article reviews the effects of legislation on medical innovation as well as the impact on continuing medical education. © 2011 Society for Vascular Surgery.

Cite

CITATION STYLE

APA

Kimmelstiel, C. (2011). Restrictions on interactions between doctors and industry could ultimately hurt patients. Journal of Vascular Surgery, 54(3 SUPPL.), 12S-14S. https://doi.org/10.1016/j.jvs.2011.05.102

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free